Kiromic BioPharma Inc.

0.87
-0.13 (-13.00%)
At close: Jan 17, 2025, 3:20 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -20.95M -34.73M -25.59M -19.20M -3.73M -3.82M
Depreciation & Amortization 2.22M 1.67M 469.80K 200.00K 87.50K 80.90K
Stock-Based Compensation 141.30K 1.24M 3.76M 13.25M 522.90K 633.00K
Other Working Capital 1.82M 562.90K -710.60K -386.80K -25.60K 320.20K
Other Non-Cash Items 574.80K 3.70M 324.20K 200.00 20.50K 633.10K
Deferred Income Tax n/a n/a n/a 22.20K n/a n/a
Change in Working Capital -3.21M 4.37M 710.30K -394.50K 183.10K 315.80K
Operating Cash Flow -21.23M -23.75M -20.32M -6.13M -2.91M -2.15M
Capital Expenditures -206.60K -4.88M -1.89M -1.46M -302.70K -137.30K
Acquisitions n/a 15.00K 84.00K n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a 15.00K -372.00K n/a n/a n/a
Investing Cash Flow -206.60K -4.87M -1.81M -1.46M -302.70K -137.30K
Debt Repayment 23.44M 4.10M 92.20K 468.00K 250.00K 725.00K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -111.20K -200.00K -2.76M 3.00M 4.51M 900.00K
Financial Cash Flow 23.99M 3.90M 37.34M 15.81M 4.76M 1.63M
Net Cash Flow 2.56M -24.71M 15.20M 8.22M 1.54M -665.20K
Free Cash Flow -21.43M -28.63M -22.22M -7.58M -3.22M -2.29M